Vancouver, British Columbia--(Newsfile Corp. - July 5, 2018) - Cannvas MedTech Inc. (CSE: MTEC) is the latest new listing on the
Canadian Securities Exchange. The company, formerly a wholly-owned subsidiary of PUF Ventures, was spun off in January 2018. Based
in Toronto, Cannvas operates in the cannabis health sciences space.
InvestmentPitch Media has produced a "video" which
provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cannvas" in the search box.
Management plans to leverage its intimate knowledge of technology and mobile applications with the new world economy of medical
and recreational cannabis.
Shawn Moniz, CEO, stated: "The listing for Cannvas on the CSE represents the culmination of considerable hard work and effort
by an exceptional and dedicated team who believe in the significant potential of our company and our technology. Medical cannabis
has emerged to become an important economic and healthcare issue with a significant potential to improve the health and wellness of
patients worldwide. Our first offering is a scalable, patient-centric life sciences learning platform for the cannabis space. From
patients and consumers to medical practitioners and licensed producers, our platform will allow for global interaction and define
the future face of cannabis education. By listing on the CSE, we hope to gain access to capital to grow our business and continue
our journey toward becoming a leading business technology company within the cannabis space."
The company's core platform is currently focused on preparing an online repository of medical cannabis related information that
pertains to a range of participants in the cannabis industry. Specifically, Cannvas is leveraging enterprise technology to create a
learning platform that is intended to allow medical practitioners, licensed producers, patients and consumers to access cannabis
education.
Cannvas is made up of four connected divisions offering design and execution expertise across advanced technology, data,
blockchain, and creative disciplines.
For more information, please visit the company's website at www.CannvasMedTech.com, contact Tim McNulty, Investor Relations, at 1-800-489-0116 or by email at ir@CannvasMedTech.com.
About InvestmentPitch Media
InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story
ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing
short videos based on significant news releases, research reports and other content of interest to investors.
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
